FOLH1 and prostate carcinoma: The prostate‐specific membrane antigen (PSMA) is a type II transmembrane glycoprotein expressed in normal prostate epithelial cells and overexpressed on nearly all prostate cancer cells,29, 30, 31 with the highest expression levels found in advanced stages like CRPC.29, 32, 33, 34